Milner Head of AI expands role across Milner Institute and Yonsei University
We are delighted to share that Dr Namshik Han, Head of AI and Computational Research at the Milner Therapeutics Institute, has begun a new role as Professor at Yonsei University in Seoul, South Korea. Namshik will divide his time between Yonsei University and the...
Milner Institute announced as finalist for 2025 OBN Award
We are delighted to share that the Milner Therapeutics Institute has been announced as a finalist for a 2025 OBN Award in the category of Most Impactful Industry Collaboration! We have been recognised for the Functional Genomics Screening Laboratory (FGSL), a...
Milner Institute connects pioneering science with investment at its 2025 Pitch Day
Last week, we were proud to host our 2025 Pitch Day, bringing together a vibrant mix of biotech innovators, investors, and translational science leaders. The event provided a high-energy platform for emerging companies to showcase bold new approaches across oncology,...
Milner Therapeutics Symposium showcases innovation in translational science
This week, the Milner Therapeutics Institute hosted its annual Symposium – a hybrid event welcoming approximately 500 in-person delegates and 250+ online attendees. Hosted at West Road Concert Hall in Cambridge, UK, the Symposium brings together leading minds from...